Management of Cough in Patients with Controlled Hypertension

Introduction to Safe Medication Options

The American College of Cardiology/American Heart Association (ACC/AHA) guidelines specifically identify decongestants (phenylephrine, pseudoephedrine) as problematic agents that should be avoided in patients with uncontrolled hypertension, but do not list guaifenesin or dextromethorphan as blood pressure-elevating medications 1
Antihistamines and non-decongestant cough medications like those in Mucinex DM are not identified as concerning for patients with hypertension, unlike sympathomimetic decongestants 2

Decongestants (pseudoephedrine, phenylephrine) should be avoided or used for the shortest duration possible in patients with severe or uncontrolled hypertension due to their sympathomimetic effects 1
Patients should be counseled to avoid combination products that contain decongestants (e.g., Mucinex D, which contains pseudoephedrine), as these formulations can elevate blood pressure 1

Patients with hypertension should continue regular blood pressure monitoring to ensure control is maintained, with target blood pressure ideally at <130/80 mmHg 2, 3
Patients should inform their healthcare provider about all medications they are taking, including over-the-counter products, to assess for potential interactions with their antihypertensive regimen 2

For patients with controlled hypertension needing cough/cold relief, safe options include guaifenesin alone, dextromethorphan alone, or combination products (Mucinex DM) 1, 2
Any product containing pseudoephedrine, phenylephrine, or other decongestants should be avoided 1
Alternative approaches include nasal saline, intranasal corticosteroids, non-sedating antihistamines like loratadine 1, 2
Systemic NSAIDs (ibuprofen, naproxen) should be avoided as they can worsen blood pressure control; consider acetaminophen for pain/fever instead 1